{
  "id": "MM_core",
  "name": "Multiple Myeloma Core Pathways",
  "description": "Essential pathways involved in multiple myeloma pathogenesis and therapeutic targeting",
  "genes": ["TP53", "BRAF", "KRAS", "NRAS", "MYC", "CCND1", "RB1", "ATM", "BRCA1", "BRCA2"],
  "diseases": ["Multiple Myeloma", "Plasma Cell Disorders"],
  "drug_targets": ["BRAF", "MEK", "PARP", "CDK4/6", "BCL2"],
  "mechanism": "Multiple myeloma is driven by dysregulation of cell cycle control (TP53, RB1), MAPK signaling (BRAF, RAS), DNA repair (BRCA1/2, ATM), and apoptosis (BCL2). These pathways represent key therapeutic targets.",
  "helper_copy": "Multiple myeloma involves multiple interconnected pathways. Understanding which pathways are disrupted helps predict which treatments will be most effective and identify resistance mechanisms.",
  "provenance": {
    "source": "synthetic_demo",
    "created_at": "2024-01-15T10:00:00Z",
    "sha256": "mno345pqr678",
    "curator": "CrisPRO.ai KB Team",
    "license": "Internal use only"
  }
}



